Mark Veich is Vice President, Philanthropy and the Executive Director of The Deerfield Foundation and joined the Firm in 2020. Prior to Deerfield, Mr. Veich was Vice Provost of External Affairs at Weill Cornell Medicine, where he served as a member of Weill Cornell’s leadership team, as well as principal adviser to the Weill Cornell Medicine Board of Overseers and its Chairman. In this capacity, Mr. Veich ensured alignment and collaboration with Cornell University on strategic priorities and collaborated closely with Cornell’s clinical partner, NewYork-Presbyterian, as well as Memorial Sloan Kettering Cancer Center, Rockefeller University, and Hospital for Special Surgery. Before Weill Cornell, he spent a decade as Managing Director of Development at Michigan Medicine, the University of Michigan’s health system, where he led teams of fundraising professionals, built global partnerships with other academic institutions, engaged board and volunteer leadership, and collaborated with faculty. Mr. Veich holds a B.A. in Administration of Justice from Southern Illinois University.
Launched in 1994, Deerfield Management Company is an investment firm dedicated to advancing healthcare through information, investment, and philanthropy—all toward the end goal of cures for disease, improved quality of life, and reduced cost of care.
Read More
Investment
Supporting companies across the healthcare ecosystem with flexible funding models…
Read MoreFeatured
Deerfield Management and the University of North Carolina Eshelman School of Pharmacy Launch Biotherapeutics Certificate Program Bridging Academia and Industry Deerfield Management Launches Joint Venture with Horizon Blue Cross Blue Shield of New Jersey Elion Therapeutics Closes $81 Million Series B Funding Round Led by Deerfield Management and AMR Action Fund
Portfolio Companies
Deerfield generally maintains a combined portfolio of more than 150 private and public investments across the life science, medical device, diagnostic, digital health and health service industries at all stages of evolution from start-up to mature company.
Read More View Portfolio Companies
Research Collaborations
Deerfield partners with leading academic research centers, providing critical funding and expertise to further sustain and accelerate the commercialization of discoveries toward meaningful societal impact by advancing cures for disease.
Read More View Research Collaborations
Strategic Partners
As a strategic partner, Deerfield offers capital, scientific expertise, business operating support, and unique access to innovation.
Read More
Deerfield Foundation
The Deerfield Foundation is a New York City-based not-for-profit organization whose mission is to improve health, accelerate innovation and promote human equity.
Read More Meet the Foundation TeamFoundation Partners by Focus
Children's Health Diversity Initiatives Maternal Health View AllFounded Diversity Programs
Break into the Boardroom Fellowships Science to the Street (formerly Women in Science)
Cure Campus
Cure is a 12-story innovation campus in New York City that intends to bring together innovators from academia, government, industry, and the not-for-profit sectors to advance human health and accelerate the fight against disease.
Read More Join the Cure Email ListCure Programming
Cure has a series of expert lectures intended to advance thought in healthcare, management, innovation, policy, and other relevant subjects. This fosters growth and education for those at Cure and its guests.
Events at the Cure